A Human Clinical Trial Evaluating the Effect of MealShape™ on Blood Glucose Level Following Consumption of Standard Meal

Inclusion Criteria: * Healthy male and female volunteers, able to read and write, aged from 18 to 45 years inclusive at time of screening * Good physical condition * Body Mass Index (BMI) ≥ 18,5 and \< 25 kg/m² * Written informed consent provided prior to screening, after receiving and understanding the subject information * Stable body weight (\< 5% variation) within the last 3 months prior to screening. * Subject accepting to keep the same lifestyle throughout the study regarding physical activity, no smoking etc. * Registered with the French Social Security, in agreement with the French law on biomedical experimentation. Exclusion Criteria: * Subject with type 1 or 2 diabetes * Smoker. Light smoker (less than 5 cigarettes per day) or former smoker (smoking more than 5 cigarettes per day) having stopped less than three months. Smoking (or use of smoking substitute e.g. nicotine patch) is not permitted from screening throughout the study. * Subject with fasting capillary blood glucose level \> 110 mg/dl. * Subject with fasting capillary blood glucose level ≤ 110 mg/dl and 2 hours postprandial capillary blood glucose level \> 140 mg/dl during an Oral Glucose Tolerance Test. * Subject with any sensitivity or allergy to any of the products used within this clinical trial. * Intake of product (food and dietary supplement) having an effect on glycemia and insulinemia. * Intake of all chronic medication excepted oestroprogestative or progestative contraception started at least three months preceding the screening visit.